Sarah Fitt: Pharmac CEO on the $1.7 billion funding-boost in the upcoming Budget
Listen now
Description
Pharmac's record funding-boost will address the fiscal cliff it faces.  An additional $1.7 billion spread over four-years has been ear-marked for the drug-buying agency in the upcoming Budget.  Chief Executive Sarah Fitt told Mike Hosking that the extra cash covers time-limited funding for some treatments, which ends this year.  She says the fiscal hole was always known, as the funds outlined in Budget 2022 only went through to Budget 2024.  LISTEN ABOVE    See omnystudio.com/listener for privacy information.
More Episodes
Australia's treasurer says the number one priority of his Budget is easing the cost of living.   Jim Chalmers is reporting a $9.3 billion surplus for this year but anticipates deficits for the next two years.   He's outlined benefits like energy relief for all households and increased rent...
Published 05/14/24
Published 05/14/24
Changes to the Christchurch Call are being welcomed by the Muslim community.  The initiative's becoming a charitable foundation and will no longer rely on taxpayer funding.  It will continue its mission to reduce online extremism but is no longer linked to the governments of New Zealand or...
Published 05/14/24